R1	Has_value Arg1:T3 Arg2:T4	
*	OR T1 T2
*	OR T6 T7
*	OR T8 T9 T10
R2	Subsumes Arg1:T6 Arg2:T8	
R3	Has_index Arg1:T14 Arg2:T15	
R4	Has_temporal Arg1:T13 Arg2:T14	
R5	Has_value Arg1:T17 Arg2:T18	
R6	Has_temporal Arg1:T17 Arg2:T19	
R7	Has_index Arg1:T19 Arg2:T20	
R8	Has_qualifier Arg1:T22 Arg2:T23	
R9	Has_negation Arg1:T22 Arg2:T21	
R10	Has_qualifier Arg1:T27 Arg2:T28	
R11	Has_negation Arg1:T27 Arg2:T21	
*	OR T29 T30 T31
R12	Subsumes Arg1:T27 Arg2:T29	
*	OR T24 T25
R13	Subsumes Arg1:T25 Arg2:T26	
R14	Subsumes Arg1:T22 Arg2:T24	
T1	Person 0 4	Male
T2	Person 9 15	female
T3	Person 37 41	ages
T4	Value 45 56	18-65 years
T5	Informed_consent 69 161	Patients (or legal representative) willing and able to provide written Informed Consent Form
T6	Condition 206 219	schizophrenia
T7	Condition 223 239	bipolar disorder
T8	Measurement 258 315	Diagnostic and Statistical Manual of Mental Disorders- IV
T9	Measurement 317 373	Diagnostic and Statistical Manual of Mental Disorders- V
T10	Measurement 377 415	International Code of Disease criteria
T13	Condition 444 461	agitation episode
T14	Temporal 486 524	within the 6 months prior to screening
T15	Reference_point 515 524	screening
T16	Drug 597 604	ADASUVE
T17	Measurement 691 702	CGI-I score
T18	Value 706 712	1 or 2
T19	Temporal 716 763	2 hours after administration of the inhalation)
T20	Reference_point 730 763	administration of the inhalation)
T21	Negation 774 778	free
T22	Condition 789 808	respiratory disease
T23	Qualifier 782 788	active
T24	Condition 817 840	acute respiratory signs
T25	Condition 817 834;841 849	acute respiratory symptoms
T26	Condition 857 865	wheezing
T27	Condition 882 897	airways disease
T28	Qualifier 875 881	active
T29	Condition 899 905	asthma
T30	Condition 907 944	chronic obstructive pulmonary disease
T31	Condition 948 957	emphysema
T34	Non-query-able 961 1342	Requirement of family or other caregiver support at study investigator criteria (defined as a patient's relative or caregiver (male or female) = 80 year old, who spend = 3 consecutive hours with patient, with good physical and psychological health status and without physical limitations, reading and writing educational level and able to understand and follow the study procedures
T35	Non-query-able 1346 1455	Availability of patient's medical records data about the previous treatment with ADASUVEÂ® at hospital setting
T36	Pregnancy_considerations 1458 1885	If a female is of childbearing potential and sexually active (except if female is surgically sterile or post-menopausal with history of no menses for at least 24 months), patient must be non-lactating and non-pregnant (with a negative pregnancy test result at baseline visit) and have to agree to use a medically acceptable and effective birth control method throughout the study and for one week following the end of the study
